Evaluation of the GORE® Ascending Stent Graft
NCT: NCT05800743 · ENROLLING_BY_INVITATION
NCT IDNCT05800743
StatusENROLLING_BY_INVITATION
Start Date2023-11-28
Completion2034-01
Brief Summary
The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.
Frequently Asked Questions
What is Evaluation of the GORE® Ascending Stent Graft?
Evaluation of the GORE® Ascending Stent Graft is a clinical trial registered under NCT05800743. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT05800743?
The current status of NCT05800743 (Evaluation of the GORE® Ascending Stent Graft) is: ENROLLING_BY_INVITATION.
When did Evaluation of the GORE® Ascending Stent Graft start?
Evaluation of the GORE® Ascending Stent Graft started on 2023-11-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.